Cobra Biologics

Epilepsy gene therapy candidate moves closer to clinical study phase
Biopharma Reporter
Thu, 09/17/20 - 10:46 am
CombiGene
Cobra Biologics
CDMOs
gene therapy
epilepsy
CG01